Past SARS-CoV-2 Infection Protection Against Reinfection Systematic Review and Meta-Analysis Estimates
GHDx Entry last modified on: Mar 28, 2023
COVID-19
Dataset Records for COVID-19
Displaying 1 - 50 of 1256
Past SARS-CoV-2 Infection Protection Against Reinfection Systematic Review and Meta-Analysis Estimates
Philippines Demographic and Health Survey 2022
2022 Philippine National Demographic and Health Survey (NDHS)
Survey:
Cross-sectional - GPS coordinates (GIS) - Household - Individual - Nationally representative - Subnationally representative - Urban-rural representative
WHO Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic 2021 - Round 3
GHDx Entry last modified on: Aug 4, 2023
Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity? Preprint
GHDx Entry last modified on: May 12, 2022
Premise Malaria COVID-19 Health Services Disruption Survey 2021
Survey:
Cross-sectional - Individual
Premise Women's Health COVID-19 Health Services Disruption Survey 2021
Survey:
Cross-sectional - Individual
Federal Ministry of Health Implements Massive Distribution of Personal Protective Equipment to Primary Healthcare Centres in Nigeria
GHDx Entry last modified on: May 12, 2022
Premise Child Health COVID-19 Health Services Disruption Survey 2021
Survey:
Cross-sectional - Individual
Premise Education COVID-19 Health Services Disruption Survey 2021
Survey:
Cross-sectional - Individual
Premise General Population COVID-19 Health Services Disruption Survey 2021
Survey:
Cross-sectional - Individual
Premise Infant and Maternal Health COVID-19 Health Services Disruption Survey 2021
Survey:
Cross-sectional - Individual
Presence of antibodies to SARS-CoV-2 in Sweden, 26 April - 9 May 2021
Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021
Survey:
Epi surveillance
Andhra Pradesh: '59% found to have Covid antibodies in sero-survey'
Survey:
Epi surveillance
[Seroprevalence to SARS-CoV-2 among the population of the Belgorod Region amid the COVID-19 epidemic]
GHDx Entry last modified on: Mar 14, 2022
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Sep 13, 2022
Jharkhand: 45% of population in 10 districts positive before 2nd wave: Sero survey
Survey:
Epi surveillance
Portugal National Serological Survey COVID-19 (2nd phase) 2021
Inquérito Serológico Nacional COVID-19 (2.ª fase) (INS COVID-19)
Survey:
Individual
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase
Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021.
Survey:
Epi surveillance
Netherlands - Coronavirus antibodies in an average of 18.6% of the donors
Antistoffen coronavirus bij gemiddeld 18,6% van de donors
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Maternal Outcomes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Compared With Unvaccinated Pregnant Patients
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
GHDx Entry last modified on: Apr 10, 2023
Russia Natural Movement of the Population 2021
Естественное Движение Населения В Разрезе Субъектов Российской Федерации За 2021 Года
Vital registration:
Subnationally representative
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
GHDx Entry last modified on: Apr 10, 2023
COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada. Preprint.
GHDx Entry last modified on: Nov 5, 2021
Yemen Supreme National Emergency Committee for COVID-19 Daily Report 2021
GHDx Entry last modified on: Aug 24, 2023
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic
GHDx Entry last modified on: Apr 10, 2023
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey
Survey:
Epi surveillance
Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Herd Immunity of the Kyrgyz Population in 2021. Preprint
GHDx Entry last modified on: Apr 8, 2022
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Germany Digital Vaccination Rate Monitoring for COVID-19 2021-2022
Digitales Impfquotenmonitoring zur COVID-19-Impfung
Bhutan Royal Centre for Disease Control Quarterly Bulletin: First Quarter, Volume 25, January-March 2021
RCDC 1st Quarterly Bulletin Volume 25, Jan -March 2021
Epi surveillance:
Subnationally representative
Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study)
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant
GHDx Entry last modified on: May 12, 2022
India COVID-19 Crowdsourced Patient Database: Vaccine Doses Administered by State
GHDx Entry last modified on: Nov 15, 2022
Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comté Hospital, France
GHDx Entry last modified on: Apr 10, 2023
United States COVID-19 Data Tracker Vaccinations 2021-2022
CDC COVID Data Tracker
Administrative data:
Epi surveillance
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study
GHDx Entry last modified on: Apr 10, 2023
Benin Health Statistical Yearbook 2021
Annuaire Des Statistiques Sanitaires Annee 2021
Report:
Epi surveillance - Nationally representative - Urban-rural representative
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study. Preprint
GHDx Entry last modified on: May 12, 2022
Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India
GHDx Entry last modified on: Mar 14, 2022
Subscribe